NovoCure Ltd (NASDAQ: NVCR) stock closed at $19.23 on 2/27/25 after a major decline of -12.4%. Moreover, this decline was accompanied by exceptionally high trading volume at 312% of normal. The stock has declined -11.8% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
NovoCure has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. NovoCure has a very low Appreciation Score of 9 but a good Power Rating of 74, resulting in the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment